| Dr Richard S Nelson, MD | |
|
18 Foundry St, Suite 201, Concord, NH 03301-5421 | |
| (603) 228-0071 | |
| (603) 227-7535 |
| Full Name | Dr Richard S Nelson |
|---|---|
| Gender | Male |
| Speciality | |
| Experience | Years |
| Location | 18 Foundry St, Concord, New Hampshire |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1386684017 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 9194 (New Hampshire) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Richard S Nelson, MD 18 Foundry St, Suite 201, Concord, NH 03301-5421 Ph: (603) 228-0071 | Dr Richard S Nelson, MD 18 Foundry St, Suite 201, Concord, NH 03301-5421 Ph: (603) 228-0071 |
News Archive
Three studies coming out of the American Epilepsy Society's 67th Annual Meeting in Washington DC expose the high prevalence of epilepsy and other neurological disorders in US Veterans who served in Operation Enduring Freedom, Operation Iraqi Freedom and Operation New Dawn. The research conducted from these studies indicate that veterans are at a particularly high risk for traumatic brain injury, post traumatic stress disorder, psychological non-epileptic seizures and epileptic seizure diagnoses.
Mayo Clinic announced today that it has received a five-year, $11 million grant from the National Cancer Institute to study survivorship in patients with non-Hodgkin lymphoma (NHL). The Lymphoma Epidemiology of Outcomes Cohort Study will enroll 12,000 patients with NHL. The study will follow these patients for long-term prognosis and survivorship.
​Polycystic Ovarian Syndrome (PCOS), a common disorder that impairs fertility by impacting menstruation, ovulation, hormones, and more, is closely related to insulin levels. Women with the disorder are typically "insulin resistant" - their bodies produce an overabundance of insulin to deliver glucose from the blood into the muscles.
The immunosuppressive drug fingolimod (trade name: Gilenya-) is approved for the treatment of highly-active relapsing-remitting multiple sclerosis (RRMS) in adults. In an early benefit assessment pursuant to "Act on the Reform of the Market for Medicinal Products" (AMNOG), the German Institute for Quality and Efficiency in Health Care (IQWiG) assessed whether fingolimod offers an added benefit compared with the present standard therapy.
› Verified 8 days ago
Dr. Ana V Castellanos Mendez, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 250 Pleasant St, Concord, NH 03301 Phone: 603-228-7200 Fax: 603-227-7562 | |
Dr. Peter Abdalla, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 250 Pleasant St, Concord, NH 03301 Phone: 603-227-7000 Fax: 603-227-7191 | |
Dr. Robert Gabrielli, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 250 Pleasant St, Concord, NH 03301 Phone: 603-485-8441 Fax: 603-485-7718 | |
Dr. Edward G. Benoit, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 60 Commercial St, Suite 401, Concord, NH 03301 Phone: 603-228-7555 Fax: 603-227-7529 | |
Dr. Fu Sheng Wang, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 250 Pleasant St, Concord, NH 03301 Phone: 603-228-7000 Fax: 603-228-7307 | |
Ms. Sabrina Bolianites, ARNP Family Medicine Medicare: Medicare Enrolled Practice Location: 250 Pleasant St Fl 2, Concord, NH 03301 Phone: 603-622-6484 Fax: 603-647-8593 | |
Pralhad Shankar Bide, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 250 Pleasant St, Chfhc, Yeaple, Concord, NH 03301 Phone: 603-228-7200 Fax: 603-228-7307 |